Newsroom
March 25, 2021
Bioventus Inc. Reports Fourth Quarter and Full Year 2020 Financial Results; Introduces Full Year 2021 Financial Guidance
DURHAM, NC – March 25, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today…
March 11, 2021
Bioventus Reports First Patients Enrolled in Phase 1 Clinical Trial of MOTYS(TM) (PTP-001) for the Treatment of Knee OA
DURHAM, NC – March 11, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a leader in solutions for innovative healing, reported…
March 4, 2021
Larry Chen Joins Bioventus as Managing Director, China and Asia Pacific
DURHAM, NC – March 4, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has…
March 1, 2021
Bioventus to Release Fourth Quarter and Fiscal Year 2020 Financial Results on March 25, 2021
DURHAM, NC – March 1, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today…
February 10, 2021
Bioventus Announces Pricing of Initial Public Offering
DURHAM, NC – February 10, 2021 – Bioventus Inc. ("Bioventus" or the “Company”) today announced the pricing of its initial public offering of…
February 4, 2021
Bioventus Announces Launch of Initial Public Offering
DURHAM, NC – February 4, 2021 – Bioventus Inc. ("Bioventus" or the “Company”), today announced that it has commenced the initial public offering of…
January 19, 2021
Miguel O. Beltrán-Delgado Joins Bioventus as Senior Vice President of Operations
DURHAM, NC – January 19, 2021 – Bioventus, a global leader in Innovations For Active Healing, has appointed Miguel O. Beltrán-Delgado as Senior Vice…
November 18, 2020
Bioventus Receives Authorization to Proceed Under Investigational New Drug Application for Clinical Trial of Placental Tissue Particulate (PTP-001) for the Treatment of Knee OA
DURHAM, NC – November 18, 2020 – Bioventus, a leader in Solutions For Innovative Healing, received authorization to proceed under its investigational…
November 16, 2020
Bioventus Appoints Chris Yamamoto Senior Vice President of Business Development and Strategy
DURHAM, NC – November 16, 2020 – Bioventus, a global leader in Innovations For Active Healing, has appointed Chris Yamamoto as Senior Vice President…
November 10, 2020
Bioventus to Provide CVS Caremark with its Portfolio of Preferred Options for Knee Osteoarthritis Patients Seeking Pain Relief
DURHAM, NC – November 10 – Beginning January 1, 2021 Bioventus, a global leader in Innovations For Active Healing, will gain preferred access through…
Search News
Media Inquiries
Thomas Hill
Director of Corporate Communications
919.474.6715
[email protected]
Download Library
Corporate and Brand Logos
Download Now
Product Images
Download Now
